Форма представления | Российские монографии |
Год публикации | 2022 |
Язык | андийский |
|
Аймалетдинов Александр Маазович, автор
|
Библиографическое описание на языке оригинала |
Tendons have a limited capacity to repair both naturally and following clinical interventions. Damaged tissue often presents with structural and functional differences, adversely affecting animal performance, mobility, health and welfare. Advances in cell therapies have started to overcome some of these issues, however complications such as the formation of ectopic bone remain a complication of this technique. Regenerative medicine is therefore looking towards future therapies such as the introduction of microvesicles (MVs) derived from stem cells (SCs). The aim of the present study was to assess the characteristics of artificially derived MVs, from equine mesenchymal stem cells (MSCs), when delivered to rat tendon cells in vitro and damaged tendons in vivo. The initial stages of extracting MVs from equine MSCs and identifying and characterising the cultured tendon stem/progenitor cells (TSCs) from rat Achilles |
Ключевые слова |
Tendon, Stem/progenitor cell, Microvesicle, Differentiation, Membrane fusion |
Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на эту карточку |
https://repository.kpfu.ru/?p_id=284796 |
Полная запись метаданных |
Поле DC |
Значение |
Язык |
dc.contributor.author |
Аймалетдинов Александр Маазович |
ru_RU |
dc.date.accessioned |
2022-01-01T00:00:00Z |
ru_RU |
dc.date.available |
2022-01-01T00:00:00Z |
ru_RU |
dc.date.issued |
2022 |
ru_RU |
dc.identifier.citation |
Tendons have a limited capacity to repair both naturally and following clinical interventions. Damaged tissue often presents with structural and functional differences, adversely affecting animal performance, mobility, health and welfare. Advances in cell therapies have started to overcome some of these issues, however complications such as the formation of ectopic bone remain a complication of this technique. Regenerative medicine is therefore looking towards future therapies such as the introduction of microvesicles (MVs) derived from stem cells (SCs). The aim of the present study was to assess the characteristics of artificially derived MVs, from equine mesenchymal stem cells (MSCs), when delivered to rat tendon cells in vitro and damaged tendons in vivo. The initial stages of extracting MVs from equine MSCs and identifying and characterising the cultured tendon stem/progenitor cells (TSCs) from rat Achilles |
ru_RU |
dc.identifier.uri |
https://repository.kpfu.ru/?p_id=284796 |
ru_RU |
dc.language.iso |
ru |
ru_RU |
dc.subject |
Tendon |
ru_RU |
dc.subject |
Stem/progenitor cell |
ru_RU |
dc.subject |
Microvesicle |
ru_RU |
dc.subject |
Differentiation |
ru_RU |
dc.subject |
Membrane fusion |
ru_RU |
dc.title |
Artificial microvesicles: new perspective on healing tendon wounds |
ru_RU |
dc.type |
Российские монографии |
ru_RU |
|